Evidence map›Paper›PMID 25324898›Full record

ArticleMolecular cytogenetics2014

The first patient with a pure 1p36 microtriplication associated with severe clinical phenotypes.

Fang Xu, Ya-Nan Zhang, De-Hua Cheng, Ke Tan, Chang-Gao Zhong, Guang-Xiu Lu, Ge Lin, Yue-Qiu Tan

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular cytogenetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Human pantothenate kinase 4 is a pseudo-pantothenate kinase.Protein science : a publication of the Protein Society · 2019
    Article
  3. Article
  4. 1p36 deletion syndrome: an update.The application of clinical genetics · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fang XuInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China ; Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078 PR China.
Ya-Nan ZhangInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China.
De-Hua ChengInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China ; Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078 PR China.
Ke TanInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China ; National Engineering and Research Center of Human Stem Cell, Changsha, 410078 PR China.
Chang-Gao ZhongInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China ; Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078 PR China.
Guang-Xiu LuInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China ; Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078 PR China ; National Engineering and Research Center of Human Stem Cell, Changsha, 410078 PR China.
Ge LinInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China ; Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078 PR China ; National Engineering and Research Center of Human Stem Cell, Changsha, 410078 PR China.
Yue-Qiu TanInstitute of Reproduction and Stem Cell Engineering, Central South University, 110# Xiangya Road, Changsha, Hunan 410078 PR China ; Reproductive and Genetic Hospital of Citic-Xiangya, Changsha, Hunan 410078 PR China.
Central South University · CNReproductive & Genetic Hospital CITIC-Xiangya · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCopy Number Variants (CNVs) is a new molecular frontier in clinical genetics. CNVs in 1p36 are usually pathogenic and have attracted the attention of cytogeneticists worldwide. None of 1p36 triplication has been reported thus far.

resultsWe present three patients with CNVs in 1p36. Among them one is the first 1p36 tetrasomy due to a pure microtriplication and the other two are 1p36 microdeletion. Traditional chromosome G-banding technique showed a normal karyotype. Single nucleotide polymorphism (SNP) microarray analysis combined with multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) were used to identify and confirm the chromosome microdeletion/microtriplication. The facial dysmorphisms of the patient with 1p36 tetrasomy differed from those two patients with 1p36 monosomy. The expression levels of B3GALT6, MIB2, PEX10 and PANK4 in the blood were determined, and differential expressions were observed between the patients and controls.

conclusionsOur study shows the first case of 1p36 tetrasomy due to a pure microtriplication in a patient with severe intellectual disability and seizures. The study provides a new resource for studying the mechanisms of microtriplication formation, and provides an evidence that overexpression of the specific genes might be related the specific phenotype of 1p36 microtriplication.

Indexed as

1p36 microdeletion1p36 microtriplicationCopy number variationsSingle nucleotide polymorphism microarray

Identifiers

PMID25324898
PMCPMC4198684
OpenAlexW2143620859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.